Earnings Preview For Applied DNA Sciences
Portfolio Pulse from Benzinga Insights
Applied DNA Sciences (NASDAQ:APDN) is scheduled to release its quarterly earnings report on February 8, 2024, with an estimated EPS of $-0.31. Investors are hopeful for a beat on this estimate and positive guidance for the next quarter. The company's past earnings performance shows a mixed impact on its stock price, with the most recent quarter resulting in an 18.43% drop despite beating the EPS estimate by $0.01. Over the last year, APDN shares have declined by 64.24%, indicating a challenging period for long-term shareholders.
February 07, 2024 | 8:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Applied DNA Sciences is expected to report an EPS of $-0.31 for the upcoming quarter. Historical data shows mixed reactions in stock price to past earnings reports, with a significant drop following the last announcement despite an EPS beat.
The anticipation of Applied DNA Sciences' earnings report and its potential to beat the EPS estimate could generate investor interest. However, the company's history of stock price volatility following earnings announcements, combined with a significant yearly decline, suggests a cautious outlook. The impact on the stock price will likely depend on whether the company can exceed expectations and provide positive guidance for the future.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100